Showing results (161-170 of 513) with videos related to
Sort By:
Pageof 52
The Analyst|September 27, 2024
Alterations of the chemical profile of cholesterol in cancer tissue as traced with ToF-SIMSAuraya Manaprasertsak, Julhash U Kazi, Catharina Hagerling, et al.Proceedings of the National Academy of Sciences of the United States of America|December 8, 2021
Preventing extreme polarization of political attitudesRobert Axelrod, Joshua J Daymude, Stephanie ForrestBJU International|July 30, 2016
Role of biobanking in urology: a reviewHeather J Chalfin, Elizabeth Fabian, Leslie Mangold, et al.Urologic Oncology|March 8, 2006
Development of the VCaP androgen-independent model of prostate cancerRobert D Loberg, Lauren N St John, LaShon L Day, et al.The Prostate|October 13, 2006
Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cellsYan-Xi Sun, Ming Fang, Jianhua Wang, et al.Urology Case Reports|April 14, 2025
PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patientVenetia A Florou, Aditya Halthore, Calixto-Hope G Lucas, et al.Molecular & Cellular Proteomics : MCP|March 16, 2025
Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological ChangesJongmin Woo, Michael Loycano, Md Amanullah, et al.The American Journal of Pathology|March 17, 2009
Regulation of prostate cancer progression by galectin-3Yi Wang, Pratima Nangia-Makker, Larry Tait, et al.Plos One|January 12, 2018
Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cellsDavid J Barakat, Rahul Suresh, Theresa Barberi, et al.Biorxiv : the Preprint Server for Biology|January 16, 2026
Drug-tolerant persister cells reallocate carbon sources to fuel antioxidant metabolism for survivalMelvin Li, Bradley Priem, Luke V Loftus, et al.Pageof 52